NuCana plc
NCNA
$0.0329
-$0.0071-17.75%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/6/2025
-
GuruFocus
5/6/2025
-
GuruFocus
5/6/2025
-
GuruFocus
5/6/2025
-
The Fly
5/6/2025
-
Globe Newswire
5/5/2025
-
GuruFocus
4/25/2025
-
Zacks Investment Research
4/24/2025
-
The Fly
4/9/2025
-
Zacks Investment Research
3/30/2025
-
Ticker Report
3/26/2025
-
Ticker Report
3/20/2025
-
GuruFocus
3/20/2025
-
The Fly
3/20/2025
-
Globe Newswire
3/18/2025
-
TipRanks Financial Blog
12/15/2024
-
Ticker Report
11/25/2024
-
SeekingAlpha.com: All News
11/25/2024
-
The Fly
11/25/2024
-
GuruFocus
11/25/2024
-
Globe Newswire
11/12/2024
-
TipRanks Financial Blog
11/11/2024
-
The Fly
11/11/2024
-
Globe Newswire
10/16/2024
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, March 20, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
44 13 1357 1111
Address
3 Lochside Way
Edinburgh, EH12 9DT
Edinburgh, EH12 9DT
Country
Year Founded
Business Description
Sector
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed...
more